Top Markets
Coin of the day
CytoMed Therapeutics Limited CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTC
주식 순위 #32324
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical... CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.
주가
$0.88
마지막 동기화: 2026-08-17
시가총액
$10.41M
변동 (1일)
-7.26%
변동 (1년)
-50.56%
국가
SG
거래 CytoMed Therapeutics Limited (GDTC)

카테고리

CytoMed Therapeutics Limited (GDTC)의 주식 분할 이력
CytoMed Therapeutics Limited 주식 (심볼: GDTC)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 18, 2026에 발생했습니다.
Aug 18, 2026 이전에 매수한 GDTC 주식 1주는 현재 0주의 GDTC 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR